GSK sets up new CRISPR lab with UC, Berkeley

10:00 EDT 13 Jun 2019 | Pharmafile

GSK has struck a $67 million deal with the University of California, Berkeley.

British multinational GlaxoSmithKline will collaborate with UC, Berkeley in using gene-editing tool CRISPR to look at the ways in which gene mutations cause disease.

The five year collaboration will see UC, Berkeley and GSK set up the Laboratory for Genomics Research (LGR) which will be led by a group of researchers including Jennifer Doudna – a co-inventor of CRISPR-Cas9.     

Image caption: 
Image Credit:

read more

Original Article: GSK sets up new CRISPR lab with UC, Berkeley


More From BioPortfolio on "GSK sets up new CRISPR lab with UC, Berkeley"

Quick Search

Relevant Topics

GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...